In preclinical investigations, MMP-9 inhibition reduced the disease severity in a mouse model of ulcerative colitis and it decreased tumor growth and metastases incidence in a surgical orthotopic xenograft model of colorectal carcinoma. Here, MMP9 is linked to ulcerative colitis.